Lumiracoxib

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

M01AH06

CAS registry number (Chemical Abstracts Service)

0220991-20-8

Chemical Formula

C15-H13-Cl-F-N-O2

Molecular Weight

293

Therapeutic Categories

Analgesic, antipyretic and anti-inflammatory agent

Non-steroidal anti-inflammatory drug, NSAID

Cyclo-oxygenase 2 (COX-2) inhibitor

Chemical Names

[2-[(2-Chloro-6-fluorophenyl)amino]-5-methylphenyl]acetic acid (WHO)

2-[2-(2-Chlor-6-fluorphenylamino)-5-methylphenyl]essigsäure (IUPAC)

Benzeneacetic acid, 2-[(2-chloro-6-fluorophenyl)amino]-5-methyl- (USAN)

Foreign Names

• Lumiracoxibum (Latin)
• Lumiracoxib (German)
• Lumiracoxib (French)
• Lumiracoxib (Spanish)

Generic Names

• Lumiracoxib (OS: USAN, BAN)
• COX-189 (IS: Novartis)
• Prexige (IS)

Brand Names

• Prexige
  Novartis, Argentina; Novartis, Brazil; Novartis, Chile; Novartis, Ecuador; Novartis, Estonia; Novartis, Georgia; Novartis, Lithuania; Novartis, Latvia; Novartis, Mexico; Novartis, Philippines; Novartis, Thailand

International Drug Name Search

Glossary

BAN	British Approved Name
IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.